Literature DB >> 6354386

Nalbuphine versus meperidine for post-operative analgesia: a double-blind comparison using the patient controlled analgesic technique.

J S Sprigge, P E Otton.   

Abstract

A double-blind study was undertaken to compare nalbuphine, a synthetic partial agonist opiate, with meperidine in providing analgesia in patients following abdominal surgery, using the patient controlled analgesic technique. Both drugs showed a wide variation in demand requirements, but they were equally effective in relieving pain as assessed by the linear analogue technique. Neither drug caused a reduction of respiratory rate. The patient-controlled analgesic technique gave analgesia of good quality and it aided the comparison of the two drugs. However, some of the patients found the technique difficult to manage, and it is expensive and time-consuming. Until further experience is gained with this device its use should be confined to a constant care unit.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354386     DOI: 10.1007/bf03007087

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  13 in total

1.  The reliability of a linear analogue for evaluating pain.

Authors:  S I Revill; J O Robinson; M Rosen; M I Hogg
Journal:  Anaesthesia       Date:  1976-11       Impact factor: 6.955

2.  A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain.

Authors:  W T Beaver; G A Feise
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

3.  Comparison of buprenorphine and pethidine given intravenously on demand to relieve postoperative pain.

Authors:  K Chakravarty; W Tucker; M Rosen; M D Vickers
Journal:  Br Med J       Date:  1979-10-13

4.  Ceiling effect for respiratory depression by nalbuphine.

Authors:  A Romagnoli; A S Keats
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

5.  Patient-controlled analgesic therapy: clinical experience.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström; U Bondesson
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1982

6.  Pain relief after abdominal surgery--a comparison of i.m. morphine, sublingual buprenorphine and self-administered i.v. pethidine.

Authors:  R Ellis; D Haines; R Shah; B R Cotton; G Smith
Journal:  Br J Anaesth       Date:  1982-04       Impact factor: 9.166

7.  Patient administration of I.V. buprenorphine for postoperative pain relief using the "Cardiff" demand analgesia apparatus.

Authors:  J M Gibbs; H D Johnson; F M Davis
Journal:  Br J Anaesth       Date:  1982-03       Impact factor: 9.166

8.  Meperidine infusion for postoperative analgesia in grossly obese patients.

Authors:  J S Sprigge; D S East; G S Fox; R I Ogilvie; P E Otton; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1982-03

9.  Patient-controlled analgesia: a new concept of postoperative pain relief.

Authors:  R L Bennett; R L Batenhorst; B A Bivins; R M Bell; D A Graves; T S Foster; B D Wright; W O Griffen
Journal:  Ann Surg       Date:  1982-06       Impact factor: 12.969

10.  Analgesic and respiratory depressant activity of nalbuphine: a comparison with morphine.

Authors:  T J Gal; C A DiFazio; J Moscicki
Journal:  Anesthesiology       Date:  1982-11       Impact factor: 7.892

View more
  4 in total

1.  Patient-controlled analgesia.

Authors: 
Journal:  Can Anaesth Soc J       Date:  1984-01

2.  Patient-controlled analgesia with nalbuphine, a new narcotic agonist-antagonist, for the treatment of postoperative pain.

Authors:  K A Lehmann; B Tenbuhs
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 3.  Newer methods of delivery of opiates for relief of pain.

Authors:  P J Slattery; R A Boas
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

4.  A comparison of nalbuphine and meperidine in treatment of postoperative pain.

Authors:  E Hew; K Foster; R Gordon; E Hew-Sang
Journal:  Can J Anaesth       Date:  1987-09       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.